[Federal Register Volume 87, Number 25 (Monday, February 7, 2022)]
[Notices]
[Page 6879]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-02476]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and/or contract proposals 
and the discussions could disclose confidential trade secrets or 
commercial property such as patentable material, and personal 
information concerning individuals associated with the grant 
applications and/or contract proposals, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; A Multilevel Approach to Connecting Underrepresented 
Populations to Clinical Trials (CUSP2CT).
    Date: March 9, 2022.
    Time: 11:00 a.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute at Shady Grove, 9609 Medical 
Center Drive, Room 7W140, Rockville, Maryland 20850 (Telephone 
Conference Call).
    Contact Person: David G. Ransom, Ph.D., Chief, Scientific Review 
Officer, Special Review Branch, Division of Extramural Activities, 
National Cancer Institute, NIH, 9609 Medical Center Drive, Room 
7W140, Rockville, Maryland 20850, 240-276-6351, 
<a href="/cdn-cgi/l/email-protection#a7c3c6d1cec389d5c6c9d4c8cae7c9cecf89c0c8d1"><span class="__cf_email__" data-cfemail="91f5f0e7f8f5bfe3f0ffe2fefcd1fff8f9bff6fee7">[email protected]</span></a>.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; The Role of Epstein Barr Virus (EBV) Infection in Non-Hodgkin 
Lymphoma (NHL) and Hodgkin Disease (HD) Development with or without 
an Underlying HIV Infection (U01).
    Date: March 24, 2022.
    Time: 9:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Room 7W104, Rockville, Maryland 20850 (Telephone 
Conference Call).
    Contact Person: Robert F. Gahl, Ph.D., Scientific Review 
Officer, Special Review Branch, Division of Extramural Activities, 
National Cancer Institute, NIH, 9606 Medical Center Drive, Room 
7W104, Rockville, Maryland 20850, 240-276-7869, <a href="/cdn-cgi/l/email-protection#80f2efe2e5f2f4aee7e1e8ecc0eee9e8aee7eff6"><span class="__cf_email__" data-cfemail="691b060b0c1b1d470e08010529070001470e061f">[email protected]</span></a>.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; R13 Conference Grant Review.
    Date: March 24, 2022.
    Time: 11:00 a.m. to 3:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute at Shady Grove, 9609 Medical 
Center Drive, Room 7W552, Rockville, Maryland 20850 (Telephone 
Conference Call).
    Contact Person: Jeanette Irene Marketon, Ph.D., Scientific 
Review Officer, Program Coordination and Referral Branch, Division 
of Extramural Activities, National Cancer Institute, NIH, 9609 
Medical Center Drive, Room 7W552, Rockville, Maryland 20850, 240-
276-6780, <a href="/cdn-cgi/l/email-protection#620807030c071616074c0f03100907160d0c220c0b0a4c050d14"><span class="__cf_email__" data-cfemail="97fdf2f6f9f2e3e3f2b9faf6e5fcf2e3f8f9d7f9feffb9f0f8e1">[email protected]</span></a>.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; TEP-11: SBIR Contract Review Meeting.
    Date: March 31, 2022.
    Time: 11:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Room 7W126, Rockville, Maryland 20850 (Telephone 
Conference Call).
    Contact Person: Susan Lynn Spence, Ph.D., Scientific Review 
Officer, Research Technology and Contract Review Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 9609 Medical 
Center Drive, Room 7W126, Rockville, Maryland 20850, 240-620-0819, 
<a href="/cdn-cgi/l/email-protection#bfcccaccded191cccfdad1dcdaffd1d6d791d8d0c9"><span class="__cf_email__" data-cfemail="62111711030c4c1112070c0107220c0b0a4c050d14">[email protected]</span></a>.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Cancer Center Support Grant.
    Date: May 12, 2022.
    Time: 2:00 p.m. to 3:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute at Shady Grove, 9609 Medical 
Center Drive, Room 7W612, Rockville, Maryland 20850 (Telephone 
Conference Call).
    Contact Person: CAPT Shari Williams Campbell, DPM, MSHS, 
Scientific Review Officer, Resources and Training Review Branch, 
Division of Extramural Activities, National Cancer Institute, NIH, 
9609 Medical Center Drive, Room 7W612, Rockville, Maryland 20850, 
240-276-7381, <a href="/cdn-cgi/l/email-protection#b2c1dad3c0db9cd1d3dfc2d0d7dedef2dcdbda9cd5ddc4"><span class="__cf_email__" data-cfemail="35465d54475c1b5654584557505959755b5c5d1b525a43">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: February 2, 2022.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-02476 Filed 2-4-22; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>